Monthly Archives: December 2018

Ex-Cleveland Clinic Innovations head sentenced to 30 months in prison for role in $2.7M fraud case

Dec 19, 2018 / Paige Minemyer The former head of Cleveland Clinic Innovations, who pleaded guilty to defrauding the health system out of nearly $3 million, was sentenced to 30 months in prison. Gary Fingerhut, 58, was also ordered to pay the more than $2.7 million that was diverted from the Cleveland Clinic as part of

By |2018-12-20T16:26:28+00:00December 20th, 2018|Regulatory|

Implantable Medical Devices Market to Reach US$49.8 Billion by 2024 End, Manufacturers Focus on Improving Biomaterial Design and Functionality, Says TMR

ALBANY, New York, December 19, 2018 /PRNewswire/ -- The global implantable medical devices market stood at US$32.3 billion in 2015. Expanding at a CAGR of 4.9% during 2016-2024, the global market will reach a worth of US$49.8 billion by the end of this period. Among the various types of biomaterials used, titanium presently hold the dominating share in the implantable medical devices market.

By |2018-12-19T20:37:50+00:00December 19th, 2018|Biologics|

Medtronic Completes Acquisition of Mazor Robotics

DUBLIN - December 19, 2018 - Medtronic plc (NYSE:MDT) today announced it has completed the acquisition of Israel-based Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ). Under the terms of the acquisition agreement announced on September 20, 2018, Mazor shareholders will receive $58.50 per American Depository Share, or $29.25 per ordinary share, in cash. The total value of the transaction

By |2018-12-19T16:40:12+00:00December 19th, 2018|Financial|

CartiHeal Performs First Agili-C™ Implant Case at The Ohio State University

KFAR SABA, Israel and COLUMBUS, Ohio, Dec. 19, 2018 /PRNewswire/ -- CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, announced today the successful enrollment of the first patient in the Agili-C Investigational Device Exemption (IDE) pivotal study at The Ohio State University Wexner Medical Center. The surgery was performed by site Investigators Dr. Christopher Kaeding and Dr. David Flanigan at

By |2018-12-19T16:04:57+00:00December 19th, 2018|Extremities|

Smith & Nephew expands opportunity in meniscal repair through acquisition of unique and highly complementary technology

18 December 2018 Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces that it has agreed to acquire Ceterix® Orthopaedics, Inc, the developer of the NovoStitch® Pro Meniscal Repair System. This unique device addresses complex meniscal tear patterns not adequately served by other repair systems. It is highly complementary to Smith & Nephew’s leading FAST-FIX◊ 360

By |2018-12-18T22:07:21+00:00December 18th, 2018|Sports Medicine|

Is your practice ready for 2019? Here are some Insights from Speakers of the 2019 Newport Beach Ortho Value-Based Care Conference

Lots is happening in the healthcare area and it’s clear that the orthopaedic fee-for-value space will continue to evolve in 2019. Here are some insights from three speakers the 3rd Interdisciplinary Conference on Orthopedic Value based Care taking place on January 18-20, 2018 in beautiful Newport Beach, California. Alexander R. Vaccaro, MD, PhD, MBA Richard

By |2018-12-18T17:36:56+00:00December 18th, 2018|Recon, Spine|

VGI Medical Surpasses 5,000 SiJoin Implants Used Throughout the United States.

Largo, FL - VGI Medical is dedicated to creating the next generation of spinal implants and procedures to improve the quality of life for its patients. One of the disruptive technologies, SiJoin, that has been developed by VGI Medical has achieved a significant milestone of over 5,000 implants used in more than 1,750 surgical procedures

By |2018-12-18T17:07:42+00:00December 18th, 2018|Spine|

Spine Surgeon Becomes First In Western Pennsylvania To Reintroduce Lumbar Artificial Disc

PITTSBURGH, PA, December 5, 2018 // — Dr. Jocelyn Idema, Orthopaedic Spine Surgeon at The Center for Disc Replacement Surgery at Advanced Orthopaedics and Rehabilitation (AOR), recently implanted Centinel Spine’s newest generation of the prodisc L lumbar artificial disc replacement.  The prodisc L® is a Total Disc Replacement (TDR) technology platform that offers a surgical alternative to spinal fusions. Patients usually

By |2018-12-18T15:48:46+00:00December 18th, 2018|Spine, Top Stories|

Johnson & Johnson Announces $5 Billion Share Repurchase Program

NEW BRUNSWICK, N.J., Dec. 17, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that the Board of Directors has authorized the repurchase of up to $5 billion of the company's common stock. "Based on our continued strong performance and, more importantly, the confidence we have in our business going forward, the Board of Directors and management team believe that

By |2018-12-17T22:48:32+00:00December 17th, 2018|Financial|

Kuros Ends Transformational Year With First MagnetOs Sales, Lead Clinical Program on Track, and Successful Capital Raise

SCHLIEREN (ZURICH), Switzerland, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX: KURN) has completed a transformational year, having realized first sales of its MagnetOs bone graft substitute in the U.S. and Europe and raised capital to support the roll-out of MagnetOs, and fund the Phase II clinical trial of fibrin-PTH (KUR-113) in spinal fusion.

By |2018-12-17T18:19:37+00:00December 17th, 2018|Biologics|